TAAR1 and lung carcinoma: Collectively, these results indicate that Tα1, by either interfering with tumor cells or modulating immune cells, can be beneficial in lung carcinoma, especially when combined with chemotherapeutic drugs that shift the pleiotropic activities of Tα1 toward tumor regression.